Literature references that cite this PDB file's
key reference
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
S.Krishnan,
and
A.A.Raibekas
(2009).
Multistep aggregation pathway of human interleukin-1 receptor antagonist: kinetic, structural, and morphological characterization.
|
| |
Biophys J, 96,
199-208.
|
 |
|
|
|
|
 |
J.R.Alford,
B.S.Kendrick,
J.F.Carpenter,
and
T.W.Randolph
(2008).
High concentration formulations of recombinant human interleukin-1 receptor antagonist: II. Aggregation kinetics.
|
| |
J Pharm Sci, 97,
3005-3021.
|
 |
|
|
|
|
 |
J.R.Alford,
S.C.Kwok,
J.N.Roberts,
D.S.Wuttke,
B.S.Kendrick,
J.F.Carpenter,
and
T.W.Randolph
(2008).
High concentration formulations of recombinant human interleukin-1 receptor antagonist: I. Physical characterization.
|
| |
J Pharm Sci, 97,
3035-3050.
|
 |
|
|
|
|
 |
R.F.Latypov,
D.Liu,
K.Gunasekaran,
T.S.Harvey,
V.I.Razinkov,
and
A.A.Raibekas
(2008).
Structural and thermodynamic effects of ANS binding to human interleukin-1 receptor antagonist.
|
| |
Protein Sci, 17,
652-663.
|
 |
|
|
|
|
 |
Z.Q.Wen,
X.Cao,
and
A.Vance
(2008).
Conformation and side chains environments of recombinant human interleukin-1 receptor antagonist (rh-IL-1ra) probed by raman, raman optical activity, and UV-resonance Raman spectroscopy.
|
| |
J Pharm Sci, 97,
2228-2241.
|
 |
|
|
|
|
 |
G.Vergoten,
and
J.P.Zanetta
(2007).
Structural differences between the putative carbohydrate-recognition domains of human IL-1 alpha, IL-1 beta and IL-1 receptor antagonist obtained by in silico modeling.
|
| |
Glycoconj J, 24,
183-193.
|
 |
|
|
|
|
 |
M.B.Seefeldt,
C.Crouch,
B.Kendrick,
and
T.W.Randolph
(2007).
Specific volume and adiabatic compressibility measurements of native and aggregated recombinant human interleukin-1 receptor antagonist: density differences enable pressure-modulated refolding.
|
| |
Biotechnol Bioeng, 98,
476-485.
|
 |
|
|
|
|
 |
Z.Q.Wen
(2007).
Raman spectroscopy of protein pharmaceuticals.
|
| |
J Pharm Sci, 96,
2861-2878.
|
 |
|
|
|
|
 |
E.Y.Chi,
B.S.Kendrick,
J.F.Carpenter,
and
T.W.Randolph
(2005).
Population balance modeling of aggregation kinetics of recombinant human interleukin-1 receptor antagonist.
|
| |
J Pharm Sci, 94,
2735-2748.
|
 |
|
|
|
|
 |
H.Tan,
G.Dan,
H.Gong,
and
L.Cao
(2005).
On-column refolding and purification of recombinant human interleukin-1 receptor antagonist (rHuIL-1ra) expressed as inclusion body in Escherichia coli.
|
| |
Biotechnol Lett, 27,
1177-1182.
|
 |
|
|
|
|
 |
M.B.Seefeldt,
Y.S.Kim,
K.P.Tolley,
J.Seely,
J.F.Carpenter,
and
T.W.Randolph
(2005).
High-pressure studies of aggregation of recombinant human interleukin-1 receptor antagonist: thermodynamics, kinetics, and application to accelerated formulation studies.
|
| |
Protein Sci, 14,
2258-2266.
|
 |
|
|
|
|
 |
S.Roy,
R.Jung,
B.A.Kerwin,
T.W.Randolph,
and
J.F.Carpenter
(2005).
Effects of benzyl alcohol on aggregation of recombinant human interleukin-1-receptor antagonist in reconstituted lyophilized formulations.
|
| |
J Pharm Sci, 94,
382-396.
|
 |
|
|
|
|
 |
Y.Zhang,
S.Roy,
L.S.Jones,
S.Krishnan,
B.A.Kerwin,
B.S.Chang,
M.C.Manning,
T.W.Randolph,
and
J.F.Carpenter
(2004).
Mechanism for benzyl alcohol-induced aggregation of recombinant human interleukin-1 receptor antagonist in aqueous solution.
|
| |
J Pharm Sci, 93,
3076-3089.
|
 |
|
|
|
|
 |
J.L.Barton,
R.Herbst,
D.Bosisio,
L.Higgins,
and
M.J.Nicklin
(2000).
A tissue specific IL-1 receptor antagonist homolog from the IL-1 cluster lacks IL-1, IL-1ra, IL-18 and IL-18 antagonist activities.
|
| |
Eur J Immunol, 30,
3299-3308.
|
 |
|
|
|
|
 |
J.K.Dattagupta,
A.Podder,
C.Chakrabarti,
U.Sen,
D.Mukhopadhyay,
S.K.Dutta,
and
M.Singh
(1999).
Refined crystal structure (2.3 A) of a double-headed winged bean alpha-chymotrypsin inhibitor and location of its second reactive site.
|
| |
Proteins, 35,
321-331.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
W.P.Arend,
M.Malyak,
C.J.Guthridge,
and
C.Gabay
(1998).
Interleukin-1 receptor antagonist: role in biology.
|
| |
Annu Rev Immunol, 16,
27-55.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|